Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01CX001803-01A2 |
| Title: | Repeated Ketamine Treatment to Accelerate Efficacy of Prolonged Exposure in PTSD |
| Principal Investigator: | Paulo R Shiroma |
| Location: | Minneapolis, MN |
| Congressional District Code: | 5 |
| Research Service: | Clinical Science R&D |
| Project Period: | January 2021 - December 2024 |
| FY 2021 Funding Amount: | $232,091 |
| Total Award Amount (all years): |
$1,191,652 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Only sertraline and paroxetine are currently FDAâapproved to treat PTSD. Other psychotropics are equally limited to provide optimal respond. This efficacy gap may be particularly great in VA settings. The 2017 VA/DoD Clinical Practice Guideline for The Management of PTSD and Acute Stress Disorder recommends individual, manualized trauma-focused such as Prolonged Exposure (PE) over other pharmacologic interventions for the primary treatment of PTSD. However, a recent review of clinical trials of... |